Volume 19 Part 1 Article 117: Screening study of ß-glucan content in commercial and wild mushroom species

Volume 19 Part 1 Article 117
Year 2016
Title: Screening study of ß-glucan content in commercial and wild mushroom species
Author: Miriam Sari, Reinhard Hambitzer, Jan Lelley

Mushrooms have a long history in culinary and medicinal usage in Asia. For years they have become the focus of international medicinal research. Besides a wide variety of health beneficial compounds like phenolic substances, sterols, alkaloids, lactones, terpenes or ceramides, bioactive polysaccharides and poly-saccharide-protein complexes are the most studied groups of functional com-pounds in medicinal mushrooms. These glucans show bioactive properties such as immunomodulating, antitumor, antiviral effects. Beta-glucans and their protein-complexes show positive results in cancer treatment. Natural immune respons-es are activated and can be used as an adjuvant therapy in combination with chemotherapy and radiotherapy. Many studies proved the positive effect of mushroom products and the increasing numbers of cancer incidences will ask for new treatments in the future1-5 The main objective of this study was the screening of ß-glucan content in cap and stalk in six commercially cultured mushrooms like Agaricus bisporus or Lentinula edodes and several wild mush-room species to maintain valuable information about content and distribution of the polysaccharide in mushroom species.

Please login to download the PDF for this proceeding.